Stay updated on Subcutaneous CDX-0159 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.

Latest updates to the Subcutaneous CDX-0159 Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study record content; the error page and site chrome replace the typical study details, indicating the content is temporarily unavailable.SummaryDifference16%

- Check39 days agoChange DetectedThe page now shows Revision: v3.7.0, a minor version update that replaces the previous v3.6.6 revision.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.6.6 was added, replacing the previous Revision: v3.6.5. This reflects a software update to the site rather than a change to the study details or content.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5. This represents a minor platform or template update rather than a change to the study details or eligibility information.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous CDX-0159 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.